Stay updated with breaking news from Cybin Pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cilo Cybin Pharmaceutical may list on the JSE within months, while it is also planning to start clinical trials of cannabis-derived drugs before the end of 2023, in partnership with its new shareholder.
/PRNewswire/ -- The "Pharmaceutical Industry in South Africa 2022" report has been added to ResearchAndMarkets.com's offering. The importance of the...
It plans to have its cannabis oils and vapes on retailers’ shelves by December.
The Money Show finds out about Cilo Cybin Pharmaceutical's latest plans from CEO Gabriel Theron.
The Money Show finds out about Cilo Cybin Pharmaceutical's latest plans from CEO Gabriel Theron.